Companies/US/EMBC

EMBECTA CORP.

Income flow

Annual
EMBC 10-K Income StatementPeriod 2025-09-30Source 10-K
Pen Needles$784MSafety$138MSyringes$125MManufacturing Facility$20MProduct And Service Other$14MRevenue$1B-4% Y/YGross profit$677M-8% Y/YCost of revenue$404MOperating profit$242M+45% Y/YOperating expenses$435MPre-tax profit$136MOther expenses$106MSG&A$332MR&D & other$103MNet profit$95M+22% Y/YTax$41M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-09-30 · 10-K · USD
By activity
By activity$1.1B
  • Pen Needles$784M72.6%
  • Safety$138M12.8%
  • Syringes$125M11.5%
  • Manufacturing Facility$20M1.8%
  • Product And Service Other$14M1.3%
By geography
By geography$1.1B
  • United States$579M53.6%
  • Non-US$501M46.4%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.64%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.2.34%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0.46PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.31.3%Shares outTotal shares currently outstanding (issued and not retired).56.7MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).54.8M
Dividend calendar
Ex-dividend
2026-08-27
Pay date
2026-09-15
Last cash
0.01 · 2026-08-27

Valuation

Trailing PE 8.4 (2025-09-30)PE trend

Fiscal PE2

PeriodEPSClosePE
2025-09-301.6213.668.4
2024-09-301.3413.089.8

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.